Recent guidelines for managing cholesterol  in people with chronic kidney disease recommend that doctors decide which drugs to prescribe on the basis of patients’ overall risk of coronary events, not just on their low-density lipoprotein or “bad” cholesterol levels.

Kidney Disease Improving Global Outcomes released the guidelines in November and say […]